Skip to content

MQUCBAPEIIGAPA-UHFFFAOYSA-M

C31H39F3N8O7P+ — CID 162571316

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPAC[4-[[4,4-diethyl-6-[[6-[1-(3-hydroxypropyl)-3-methoxypyrazol-4-yl]-2-(methylcarbamoyl)-3-pyridinyl]amino]-5-(trifluoromethyl)-1H-pyrimidin-2-yl]amino]-3-methoxyphenyl]methoxy-hydroxy-oxophosphanium
SMILESCCC1(CC)N=C(Nc2ccc(CO[P+](=O)O)cc2OC)NC(Nc2ccc(-c3cn(CCCO)nc3OC)nc2C(=O)NC)=C1C(F)(F)F
InChIInChI=1S/C31H38F3N8O7P/c1-6-30(7-2)25(31(32,33)34)26(39-29(40-30)38-21-10-9-18(15-23(21)47-4)17-49-50(45)46)37-22-12-11-20(36-24(22)27(44)35-3)19-16-42(13-8-14-43)41-28(19)48-5/h9-12,15-16,43H,6-8,13-14,17H2,1-5H3,(H4-,35,37,38,39,40,44,45,46)/p+1
InChIKeyTVWREYQVRPZLNX-UHFFFAOYSA-O
MW723.67 g/mol
LogP4.69
Rot. Bonds15

About MQUCBAPEIIGAPA-UHFFFAOYSA-M

MQUCBAPEIIGAPA-UHFFFAOYSA-M (PubChem CID 162571316) has the molecular formula C31H39F3N8O7P+ and a molecular weight of 723.67 g/mol. Its IUPAC name is [4-[[4,4-diethyl-6-[[6-[1-(3-hydroxypropyl)-3-methoxypyrazol-4-yl]-2-(methylcarbamoyl)-3-pyridinyl]amino]-5-(trifluoromethyl)-1H-pyrimidin-2-yl]amino]-3-methoxyphenyl]methoxy-hydroxy-oxophosphanium.

Molecular Properties

Compound NameMQUCBAPEIIGAPA-UHFFFAOYSA-M
PubChem CID162571316
Molecular FormulaC31H39F3N8O7P+
Molecular Weight723.67 g/mol
Exact Mass723.26
IUPAC Name[4-[[4,4-diethyl-6-[[6-[1-(3-hydroxypropyl)-3-methoxypyrazol-4-yl]-2-(methylcarbamoyl)-3-pyridinyl]amino]-5-(trifluoromethyl)-1H-pyrimidin-2-yl]amino]-3-methoxyphenyl]methoxy-hydroxy-oxophosphanium
SMILESCCC1(CC)N=C(Nc2ccc(CO[P+](=O)O)cc2OC)NC(Nc2ccc(-c3cn(CCCO)nc3OC)nc2C(=O)NC)=C1C(F)(F)F
InChIInChI=1S/C31H38F3N8O7P/c1-6-30(7-2)25(31(32,33)34)26(39-29(40-30)38-21-10-9-18(15-23(21)47-4)17-49-50(45)46)37-22-12-11-20(36-24(22)27(44)35-3)19-16-42(13-8-14-43)41-28(19)48-5/h9-12,15-16,43H,6-8,13-14,17H2,1-5H3,(H4-,35,37,38,39,40,44,45,46)/p+1
InChIKeyTVWREYQVRPZLNX-UHFFFAOYSA-O
XLogP4.69
TPSA193.48 Ų
H-Bond Donors6
H-Bond Acceptors13
Rotatable Bonds15
Heavy Atoms50
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500723.67
LogP ≤ 54.69
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze MQUCBAPEIIGAPA-UHFFFAOYSA-M with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of MQUCBAPEIIGAPA-UHFFFAOYSA-M?
The IUPAC name of MQUCBAPEIIGAPA-UHFFFAOYSA-M (CID 162571316) is [4-[[4,4-diethyl-6-[[6-[1-(3-hydroxypropyl)-3-methoxypyrazol-4-yl]-2-(methylcarbamoyl)-3-pyridinyl]amino]-5-(trifluoromethyl)-1H-pyrimidin-2-yl]amino]-3-methoxyphenyl]methoxy-hydroxy-oxophosphanium.
What is the SMILES notation for MQUCBAPEIIGAPA-UHFFFAOYSA-M?
The canonical SMILES for MQUCBAPEIIGAPA-UHFFFAOYSA-M is CCC1(CC)N=C(Nc2ccc(CO[P+](=O)O)cc2OC)NC(Nc2ccc(-c3cn(CCCO)nc3OC)nc2C(=O)NC)=C1C(F)(F)F.
What is the InChIKey of MQUCBAPEIIGAPA-UHFFFAOYSA-M?
The InChIKey is TVWREYQVRPZLNX-UHFFFAOYSA-O. The full InChI is InChI=1S/C31H38F3N8O7P/c1-6-30(7-2)25(31(32,33)34)26(39-29(40-30)38-21-10-9-18(15-23(21)47-4)17-49-50(45)46)37-22-12-11-20(36-24(22)27(44)35-3)19-16-42(13-8-14-43)41-28(19)48-5/h9-12,15-16,43H,6-8,13-14,17H2,1-5H3,(H4-,35,37,38,39,40,44,45,46)/p+1.
What are the key properties of MQUCBAPEIIGAPA-UHFFFAOYSA-M?
MQUCBAPEIIGAPA-UHFFFAOYSA-M has a molecular weight of 723.67 g/mol, XLogP of 4.69, 15 rotatable bonds, 6 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for MQUCBAPEIIGAPA-UHFFFAOYSA-M is sourced from PubChem (CID 162571316), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.